Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Iodosan is a well-established brand and former pharmaceutical company specializing in oral care and throat treatments, primarily active in the Italian market. Historically an independent entity known as Iodosan S.p.A., it was acquired by SmithKline Beecham (now GSK) in the late 1980s and is currently part of the Haleon portfolio following the spin-off of GSK's consumer healthcare division. The brand is best known for its antiseptic mouthwashes, throat sprays, and lozenges, such as Iodosan Gola, which utilize active ingredients like povidone-iodine and flurbiprofen. While it no longer operates as an independent R&D-focused biotech, it remains a significant commercial name in the consumer healthcare sector for upper respiratory and oral health indications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IODOSAN.